<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01528540</url>
  </required_header>
  <id_info>
    <org_study_id>AIG-PAN-2012-1</org_study_id>
    <nct_id>NCT01528540</nct_id>
  </id_info>
  <brief_title>Evaluation of Efficacy of Combination of Pregabalin and Antioxidant in Reducing Pain in Chronic Pancreatitis: a Randomized Control Trial</brief_title>
  <official_title>Evaluation of Efficacy of Combination of Pregabalin and Antioxidant in Reducing Pain in Chronic Pancreatitis: a RCT</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Asian Institute of Gastroenterology, India</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Asian Institute of Gastroenterology, India</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Study hypothesis: Combination of antioxidants and pregabalin results in better pain relief
      than placebo in patients with chronic pancreatitis.

      Chronic pancreatitis (CP) is a clinical enigma, with pain being the most distressing symptom
      that brings the patient to clinical attention. Pain in chronic pancreatitis is
      multifactorial, and may be related to pancreatic ductal hypertension, tissue hypertension,
      inflammatory cytokines, oxidative stress and neuropathic mechanisms like mechanical
      allodynia, inflammatory hyperalgesia and temporal summation. The mainstay of treatment for
      pain in CP due to pancreatic ductal stone is endotherapy (ESWL and ERCP). Recent randomized
      controlled trials have shown that antioxidant cocktail and pregabalin (a presynaptic voltage
      gated calcium channel blocking agent) can result in significant reduction of pain in CP.

      In this study, the investigators will study the efficacy of the combination of antioxidants
      and pregabalin in reducing pain and compare that with placebo. The investigators will
      randomize patients with documented chronic pancreatitis with recurrent/persistent pain after
      undergoing endotherapy and ductal clearance into three groups: Group A- antioxidants +
      pregabalin; Group B- Placebo. The primary outcome will be change in pain score and the
      secondary outcomes will be change in the number of painful days, analgesic requirements,
      quality of life and depression scale. Pain score will be quantified by the Izbicki pain score
      and visual analog scale; while quality of life and depression will be measured by the EORTC
      QLQ-C30/PAN26 and Beck depression inventory respectively. Comparison between Group A vs B
      will be made by the Chi square test/Fischer Exact and the Student's 't' tests respectively
      and analysis will be done on a intention to treat and per protocol basis. With an expected
      improvement of pain by 40% (at 80% power and alpha of 0.05) and adjusting for a presumed 10%
      drop out rate, the required sample size in each group will be at least 40.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2012</start_date>
  <completion_date type="Actual">December 2014</completion_date>
  <primary_completion_date type="Actual">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in the pain score</measure>
    <time_frame>Baseline and 8weeks</time_frame>
    <description>Pain score will be assessed by the Izbicki pain score, Visual analog scale and painDETECT tool for neuropathic pain.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in number of painful days</measure>
    <time_frame>Baseline and 8weeks</time_frame>
    <description>The number of days of pain per week will be measured.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in analgesic requirement</measure>
    <time_frame>Baseline and 8weeks</time_frame>
    <description>The type (opiate/non-opiate), number and route of additional analgesic medicines that were required within the study period will be evaluated.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in quality of life</measure>
    <time_frame>Baseline and 8weeks</time_frame>
    <description>QOL will be evaluated with the EORTC QLQ-C30/PAN26 questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in depression scale</measure>
    <time_frame>Baseline and 8weeks</time_frame>
    <description>Depression will be assessed with the Beck's Depression Inventory.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">87</enrollment>
  <condition>Chronic Pancreatitis</condition>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>This group will contain a placebo for antioxidant cocktail and pregabalin</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Antioxidant plus pregabalin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This group will contain antioxidant cocktail and pregabalin</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>This group will include placebo.</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Antioxidant plus Pregabalin</intervention_name>
    <description>This group will contain combination of antioxidant cocktail and pregabalin</description>
    <arm_group_label>Antioxidant plus pregabalin</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Epigastric pain +/- radiation at least thrice in one month over the past three month.

          2. Endotherapy/Surgery and ducal clearance

        Exclusion Criteria:

          1. Age &lt;18 and &gt;65yrs

          2. MPD and biliary obstruction

          3. Pancreatic neoplastic lesions

          4. Acute flare

          5. Pancreatic pseudocysts

          6. Pregnancy

          7. Cardiac and renal diseases

          8. Use of other anti epileptics

          9. Hypersensitivity to gabapentin/pregabalin
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rupjyoti Talukdar, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Asian Institue of Gastroenterology</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Asian Institute of Gastroenterology</name>
      <address>
        <city>Hyderabad</city>
        <state>Andhra Pradesh</state>
        <zip>500082</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>India</country>
  </location_countries>
  <reference>
    <citation>Bhardwaj P, Garg PK, Maulik SK, Saraya A, Tandon RK, Acharya SK. A randomized controlled trial of antioxidant supplementation for pain relief in patients with chronic pancreatitis. Gastroenterology. 2009 Jan;136(1):149-159.e2. doi: 10.1053/j.gastro.2008.09.028. Epub 2008 Sep 25.</citation>
    <PMID>18952082</PMID>
  </reference>
  <reference>
    <citation>Olesen SS, Bouwense SA, Wilder-Smith OH, van Goor H, Drewes AM. Pregabalin reduces pain in patients with chronic pancreatitis in a randomized, controlled trial. Gastroenterology. 2011 Aug;141(2):536-43. doi: 10.1053/j.gastro.2011.04.003. Epub 2011 Apr 14.</citation>
    <PMID>21683078</PMID>
  </reference>
  <verification_date>September 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 27, 2012</study_first_submitted>
  <study_first_submitted_qc>February 4, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 8, 2012</study_first_posted>
  <last_update_submitted>September 8, 2015</last_update_submitted>
  <last_update_submitted_qc>September 8, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 9, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>chronic pancreatitis</keyword>
  <keyword>pregabalin</keyword>
  <keyword>antioxidant</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pancreatitis</mesh_term>
    <mesh_term>Pancreatitis, Chronic</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pregabalin</mesh_term>
    <mesh_term>Antioxidants</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

